Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction

Heart Rhythm

Volumn 12, Issue 12, 2015, Pages 2381-2386

  Brunner, Michael P ^a   Yu, Changhong ^a   Hussein, Ayman A ^a   Tarakji, Khaldoun G ^a   Wazni, Oussama M ^a   Kattan, Michael W ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Extraction; Implantable cardioverter defibrillator; Lead; Nomogram; Pacemaker; Riskscore

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; DEVICE INFECTION; END STAGE RENAL DISEASE; EXTRACTION; FEMALE; FLUOROSCOPY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; OUTCOME ASSESSMENT; PACEMAKER; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK; RISK FACTOR; SCORING SYSTEM; TRANSVENOUS LEAD EXTRACTION; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CLINICAL DECISION MAKING; DEVICE FAILURE; DEVICE REMOVAL; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; ARRHYTHMIAS, CARDIAC; CLINICAL DECISION-MAKING; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; EQUIPMENT FAILURE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOMOGRAMS; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84960119115     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.07.024     Document Type: Article

References (19)

1. A.J. Greenspon, J.D. Patel, E. Lau, J.A. Ochoa, D.R. Frisch, R.T. Ho, B.B. Pavri, and S.M. Kurtz Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures J Am Coll Cardiol 60 2012 1540 1545
2. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, and et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 62
3. J. Camm, and S. Nisam Implantable cardioverter-defibrillator utilization Europace 13 2011 448
4. A. Voigt, A. Shalaby, and S. Saba Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights Pacing Clin Electrophysiol 33 2010 414 419
5. C.H. Cabell, P.A. Heidenreich, V.H. Chu, C.M. Moore, M.E. Stryjewski, G.R. Corey, and V.G. Fowler Jr Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999 Am Heart J 147 2004 582 586
6. W.H. Maisel Pacemaker and ICD generator reliability: meta-analysis of device registries JAMA 295 2006 1929 1934
7. J. Liu, G. Brumberg, R. Rattan, S. Jain, and S. Saba Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families Heart Rhythm 9 2012 1251 1255
8. R.G. Hauser The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators J Am Coll Cardiol 45 2005 2022 2025
9. M. Maytin, L.M. Epstein, and C.A. Henrikson Lead extraction is preferred for lead revisions and system upgrades: when less is more Circ Arrhythm Electrophysiol 3 2010 413 424
10. A. Arujuna, S. Williams, J. Whittaker, and et al. Trends, indications and outcomes of cardiac implantable device system extraction: a single UK centre experience over the last decade Int J Clin Pract 66 2012 218 225
11. M. Maytin, S.O. Jones, and L.M. Epstein Long-term mortality after transvenous lead extraction Circ Arrhythm Electrophysiol 5 2011 252 257
12. A.L. Shroyer, L.P. Coombs, E.D. Peterson, M.C. Eiken, E.R. DeLong, A. Chen, T.B. Ferguson Jr, F.L. Grover, and F.H. Edwards The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models Ann Thorac Surg 75 2003 1856 1864
13. O. Wazni, L.M. Epstein, R.G. Carrillo, and et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions J Am Coll Cardiol 55 2010 579 586
14. K.G. Tarakji, E.J. Chan, D.J. Cantillon, A.L. Doonan, T. Hu, S. Schmitt, T.G. Fraser, A. Kim, S.M. Gordon, and B.L. Wilkoff Cardiac implantable electronic device infections: presentation, management, and patient outcomes Heart Rhythm 7 2010 1043 1047
15. M.P. Brunner, E.M. Cronin, V.E. Duarte, and et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions Heart Rhythm 11 2014 799 805
16. B.L. Wilkoff, C.J. Love, C.L. Byrd, M.G. Bongiorni, R.G. Carillo, G.H. Crossley 3rd, L.M. Epstein, R.A. Friedman, C.E. Kennergren, P. Mitkowski, R.H. Schaerf, and O.M. Wazni Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA) Heart Rhythm 6 2009 1085 1104
17. J.S. Li, D.J. Sexton, N. Mick, R. Nettles, V.G. Fowler Jr, T. Ryan, T. Bashore, and G.R. Corey Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 30 2000 633 638
18. M.R. Sohail, C.A. Henrikson, M.J. Braid-Forbes, K.F. Forbes, and D.J. Lerner Mortality and cost associated with cardiovascular implantable electronic device infections Arch Intern Med 171 2011 1821 1828
19. K.G. Tarakji, O.M. Wazni, S. Harb, A. Hsu, W. Saliba, and B.L. Wilkoff Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival Europace 16 2014 1490 1495